Athos Therapeutics, Inc.

New Filing
CIK: 0001885079·Pharmaceuticals·DELAWARE·Filed: Feb 6, 2024
Total Offering

$34,999,995

Amount Sold

$7,556,334

Investors

30

First Sale

Jan 22, 2024

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506(b)

Related Persons

NameRole
Dimitrios Iliopoulos
Executive Officer, Director
Allan J. Pantuck
Executive Officer, Director
Carl McKinzie
Director
Joel Cohen
Director
Anthony Zingale
Director

Company

Athos Therapeutics, Inc.

1123 W. CARSON ST.

TORRANCE, CA, 90502

857-222-0410

SEC Filing

0001885079-24-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free